Repository logo
 

YAP/TAZ-Dependent Reprogramming of Colonic Epithelium Links ECM Remodeling to Tissue Regeneration.

Published version
Peer-reviewed

Change log

Authors

Yui, Shiro 
Azzolin, Luca 
Pedersen, Marianne Terndrup  ORCID logo  https://orcid.org/0000-0003-3808-0352
Fordham, Robert P 

Abstract

Tissue regeneration requires dynamic cellular adaptation to the wound environment. It is currently unclear how this is orchestrated at the cellular level and how cell fate is affected by severe tissue damage. Here we dissect cell fate transitions during colonic regeneration in a mouse dextran sulfate sodium (DSS) colitis model, and we demonstrate that the epithelium is transiently reprogrammed into a primitive state. This is characterized by de novo expression of fetal markers as well as suppression of markers for adult stem and differentiated cells. The fate change is orchestrated by remodeling the extracellular matrix (ECM), increased FAK/Src signaling, and ultimately YAP/TAZ activation. In a defined cell culture system recapitulating the extracellular matrix remodeling observed in vivo, we show that a collagen 3D matrix supplemented with Wnt ligands is sufficient to sustain endogenous YAP/TAZ and induce conversion of cell fate. This provides a simple model for tissue regeneration, implicating cellular reprogramming as an essential element.

Description

Keywords

YAP/TAZ, intestinal stem cells, mechano-sensing, regeneration, reprogramming, Adaptor Proteins, Signal Transducing, Animals, Biomarkers, Cell Cycle Proteins, Cellular Reprogramming, Extracellular Matrix, Fetus, Humans, Intestinal Mucosa, Mechanotransduction, Cellular, Mice, Inbred C57BL, Phosphoproteins, Regeneration, Signal Transduction, Transcription, Genetic, Transcriptional Activation, YAP-Signaling Proteins

Journal Title

Cell Stem Cell

Conference Name

Journal ISSN

1934-5909
1875-9777

Volume Title

22

Publisher

Elsevier BV
Sponsorship
Medical Research Council (MC_PC_12009)
European Commission Horizon 2020 (H2020) Societal Challenges (668294-2 INTENS)
This work was supported by Worldwide Cancer Research (13-1216 to KBJ), Lundbeck Foundation (R105-A9755 to KBJ), the Danish Cancer Society (R56-A2907 and R124-A7724 to KBJ), the Carlsberg Foundation (to KBJ), EMBO Young Investigator programme (to KBJ), AIRC Special Program Molecular Clinical Oncology ‘‘5 per mille’’ (to SP), an AIRC PI-Grant (to SP), Epigenetics Flagship projects (CNR-Miur grants. to SP), the DFF mobilix programme (to SY), Marie Curie fellowship programme (SY and JG), Foundation of Aase and Ejnar Danielsen (OHN), Axel Muusfeldts Foundation (OHN), The Ragnar Söderberg Foundation (CDM). This project has received funding from the European Union’s Horizon 2020 research and innovation programme (grant agreements STEMHEALTH ERCCoG682665 and INTENS 668294 to KBJ and DENOVOSTEM No. 670126 to SP).